Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer

NCT01942837 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: Enzalutamide

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]